Biopharma’s Survival Moment
March 2, 2026
Why the next decade will be defined by operational reinvention, not just scientific breakthroughs
5 min read
False
Advertisement
Biopharma
MHRA Approval for First UK-made mRNA Vaccine
February 27, 2026
Moderna receives MHRA approval for updated COVID-19 vaccine targeting SARS-CoV-2 variant LP.8.1
1 min read
GSK’s RSV Vaccine Moves Closer to China Approval
February 18, 2026
Regulatory filing for Arexvy has been accepted for review in China for adults aged 60 and older, where RSV affects millions each year
2 min read
Overcoming the Challenges of AI Antibody Analysis
By Ben Holland
February 4, 2026
Cracking the molecular code
5 min read
First 20mL Universal Plunger for Large-Volume On-Body Delivery
February 2, 2026
Plunger for 20mL cartridges aims to meet rising demand for on-body delivery of higher dose therapies
1 min read
Resolve M Therapeutics Exits from Stealth
January 29, 2026
Platform designed to engage pro-resolution responses to restore immune homeostasis in inflammatory disorders without broad immuno-suppression
1 min read
Beating Biopharma Manufacturing Bottlenecks with Raman Spectroscopy
By Michelle Sestak
January 26, 2026
A look at the potential of Raman spectroscopy in biopharma – and what else lies on the horizon for this important technique
4 min read
UK Increase in Advanced Therapy Clinical Trials
January 26, 2026
Number of early-stage trials remains high, according to CGT Catapult data
1 min read
New START for Kumar Muthalagappan
January 20, 2026
Entrepreneur and philanthropist will assist South Texas Accelerated Research Therapeutics (START) in its quest to expand globally
2 min read
Discussing the Big Ideas in Medicine Manufacturing: Part II
January 19, 2026
More experts share their thoughts on the next “big ideas” that they think will shape the near future of therapy developments.
10 min read
